Literature DB >> 21652514

A trio of microRNAs that control Toll-like receptor signalling.

Susan R Quinn1, Luke A O'Neill.   

Abstract

Toll-like receptors (TLRs) in the host recognize conserved microbial products and defend against pathogenic attack by initiating an immune response via signalling pathways that lead to an increase in immune and inflammatory gene expression. TLR signalling must be stringently regulated in order to ensure sufficient clearance of pathogens and a timely return to homeostasis after infection. MicroRNAs (miRNAs) are a newly discovered class of gene regulators which bind to the 3' untranslated region of target mRNA and direct their post-transcriptional repression. They are global regulators potentially controlling up to 30% of the human genome. Several miRNAs have been shown to be up-regulated in response to TLR ligands, and many directly target components of the TLR signalling system, revealing a whole extra level of control of TLR signalling which is being extensively researched. The dysregulation of miRNAs may be involved in many inflammatory diseases and cancers and thus merits further investigation. In this review, we focus in on a trio of miRNA which have proven to be key in many immune and inflammatory pathways; miR-155, miR-21 and miR-146.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21652514     DOI: 10.1093/intimm/dxr034

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  140 in total

Review 1.  Role of reactive oxygen and nitrogen species in the vascular responses to inflammation.

Authors:  Peter R Kvietys; D Neil Granger
Journal:  Free Radic Biol Med       Date:  2011-11-12       Impact factor: 7.376

Review 2.  Macrophage plasticity and polarization: in vivo veritas.

Authors:  Antonio Sica; Alberto Mantovani
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

Review 3.  Macrophage polarization in pathology.

Authors:  Antonio Sica; Marco Erreni; Paola Allavena; Chiara Porta
Journal:  Cell Mol Life Sci       Date:  2015-07-26       Impact factor: 9.261

Review 4.  Environmental epigenetics and its implication on disease risk and health outcomes.

Authors:  Shuk-Mei Ho; Abby Johnson; Pheruza Tarapore; Vinothini Janakiram; Xiang Zhang; Yuet-Kin Leung
Journal:  ILAR J       Date:  2012

5.  IRAK4 kinase activity is not required for induction of endotoxin tolerance but contributes to TLR2-mediated tolerance.

Authors:  Yanbao Xiong; Meghan Pennini; Stefanie N Vogel; Andrei E Medvedev
Journal:  J Leukoc Biol       Date:  2013-05-21       Impact factor: 4.962

6.  Attenuation of Cardiac Dysfunction in Polymicrobial Sepsis by MicroRNA-146a Is Mediated via Targeting of IRAK1 and TRAF6 Expression.

Authors:  Ming Gao; Xiaohui Wang; Xia Zhang; Tuanzhu Ha; He Ma; Li Liu; John H Kalbfleisch; Xiang Gao; Race L Kao; David L Williams; Chuanfu Li
Journal:  J Immunol       Date:  2015-06-05       Impact factor: 5.422

7.  Dysregulation in microRNA expression in peripheral blood mononuclear cells of sepsis patients is associated with immunopathology.

Authors:  Juhua Zhou; Hina Chaudhry; Yin Zhong; Mir Mustafa Ali; Linda A Perkins; William B Owens; Juan E Morales; Franklin R McGuire; Elizabeth E Zumbrun; Jiajia Zhang; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  Cytokine       Date:  2014-09-29       Impact factor: 3.861

8.  Circulating microRNAs levels in Chinese heart failure patients caused by dilated cardiomyopathy.

Authors:  Kuan-Lu Fan; Hai-Feng Zhang; Jie Shen; Qi Zhang; Xin-Li Li
Journal:  Indian Heart J       Date:  2012-12-28

Review 9.  Interplay Between Exosomes, microRNAs and Toll-Like Receptors in Brain Disorders.

Authors:  Vera Paschon; Silvia Honda Takada; Juliane Midori Ikebara; Erica Sousa; Reza Raeisossadati; Henning Ulrich; Alexandre Hiroaki Kihara
Journal:  Mol Neurobiol       Date:  2015-04-11       Impact factor: 5.590

10.  miR-146a is directly regulated by STAT3 in human hepatocellular carcinoma cells and involved in anti-tumor immune suppression.

Authors:  Xiaoxia Sun; Jian Zhang; Zhaohua Hou; Qiuju Han; Cai Zhang; Zhigang Tian
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.